glp-1 weight loss injection west chester Microdosing Therapy in Ventura Ageless is Live at StretchLab

Retatrutide is a triple-receptor agonist, the first of its kind to simultaneously activate GLP-1, GIP, and glucagon receptors

Retatrutide is suitable for research teams examining integrated metabolic signaling pathways and multi-receptor peptide interactions within controlled experimental models

- Vegetarian, gluten, dairy, soy & allergen-free

In Phase 1 and 2a clinical trials, once-daily subcutaneous injections of RG7697 (0.252.5 mg) for 14 days in 56 patients with T2DM and 1.8 mg of RG7697 for 12 weeks in patients with T2DM who were poorly responsive to metformin reduced body weight and improved glycemic control